Serum levels of interleukin (IL)-27 in patients with ischemic heart disease

Cytokine

Volumn 56, Issue 2, 2011, Pages 153-156

  Jafarzadeh, A ^a   Nemati, M ^a   Rezayati, M T ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute myocardial infarction; Interleukin 27; Unstable angina

Indexed keywords

INTERLEUKIN 27;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; IMMUNE RESPONSE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

ANGINA;

EID: 80053301608     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.06.014     Document Type: Article

References (34)

1. Tiong A.Y., Brieger D. Inflammation and coronary artery disease. Am Heart J 2005, 150:11-18.
2. Mahmoudi M., Curzen N., Gallagher P.J. Atherogenesis: the role of inflammation and infection. Histopathol 2007, 50:535-546.
3. Baidya S.G., Zeng Q.T. Helper T cells and atherosclerosis: the cytokine web. Postgrad Med J 2005, 81:746-752.
4. Skapenko A., Schulze-Koops H. Analysis of Th1/Th2 T-cell subsets. Methods Mol Med 2007, 136:87-96.
5. Cheng X., Liao Y.H., Ge H., Li B., Zhang J., Yuan J., et al. TH1/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol 2005, 25:246-253.
6. Han S.F., Li X.Y., Liu K.W., Wang L., Cui R., Qlan W., et al. Imbalance of T helper 1 cells/T helper 2 cells accelerated T-cell-mediated endothelium injury in patients with acute coronary syndromes. Zhonghua Xin Xue Guan Bing Za Zhi 2008, 36(12):1070-1073.
7. Steppich B.A., Moog P., Matissek C., Wisniowski N., Kühle J., Joghetaei N., et al. Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis 2007, 190:443-451.
8. Santana M., Rosenstein Y. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J Cell Physiol 2003, 195:392-401.
9. Villarino A.V., Huang E., Hunter C.A. Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 2004, 173(2):715-720.
10. Yoshida H., Yoshiyuki M. Regulation of immune responses by interleukin-27. Immunol Rev 2008, 226:234-247.
11. Hashmi S., Zeng Q.T. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 2006, 17:699-706.
12. Jafarzadeh A., Esmaeli-Nodimi A., Nugh H., Nemati M., Rezayati M.T. Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease. Anadolu Kardiyol Derg 2009, 9(2):75-83.
13. Zakynthinos E., Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol 2009, 53(3):317-333.
14. Jha H.C., Divya A., Prasad J., Mittal A. Plasma circulatory markers in male and female patients with coronary artery disease. Heart Lung 2010, 39(4):296-303.
15. Ridker P.M., Genest G., Libby P. Risk factors for atherosclerotic disease in Braunwald, Text book of Heart disease 2001, WB Saunders company, pp. 1028-31. 6th ed.
16. Kawasaki D., Tsujino T., Morimoto S., Masai M., Masutani M., Ohyanagi M., et al. Plasma interleukin-18 concentration: a novel marker of myocardial ischemia rather than necrosis in humans. Coron Artery Dis 2005, 16:437-441.
17. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. Major infect Immun 2001, 15:569-578.
18. Artis D., Villarino A., Silverman M., He W., Thornton E.M., Mu S., et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J Immunol 2004, 173:5626-5634.
19. Heinisch R.H., Zanetti C.R., Comin F., Fernandes J.L., Ramires J.A., Serrano C.V. Serial changes in plasma levels of cytokines in patients with coronary artery disease. Vasc Health Risk Manag 2005, 1(3):245-250.
20. Marciniak A., Gierbliński I., Stefański R., Łapiński M., Gaciong Z., Bartłomiejczyk I., et al. Predictive value of plasma interleukin 1, interleukin 6, interleukin 8 and C-reactive protein (CRP) in patients with myocardial infarction. Pol Arch Med Wewn 2003, 109(1):15-22.
21. Carl J.W., Bai X.F. IL27: its roles in the induction and inhibition of inflammation. Int J Clin Exp Pathol 2008, 1(2):117-123.
22. Cao Y., Doodes P.D., Glant T.T., Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 2008, 180(2):922-930.
23. Segerer S., Nelson P.J., Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000, 11:152-176.
24. Wuthrich R.P. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int 1992, 42:903-914.
25. Owaki T., Asakawa M., Morishima N., Hata K., Fukai F., Matsui M., et al. A role for IL-27 in early regulation of Th1 differentiation. J Immunol 2005, 175(4):2191-2200.
26. Stockinger B., Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007, 19:281-286.
27. Yoshida H., Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol Rev 2008, 226:234-247.
28. Cheng X., Yu X., Ding Y.J., Fu Q.Q., Xie J.J., Tang T.T., et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008, 127:89-97.
29. Costantino C.M., Baecher-Allan C.M., Hafler D.A. Human regulatory T cells and autoimmunity. Eur J Immunol 2008, 38(4):921-924.
30. Villarino A.V., Larkin J., Saris C.J., Caton A.J., Lucas S., Wong T., et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol 2005, 174:7684.
31. Huber M., Steinwald V., Guralnik A., Brüstle A., Kleemann P., Rosenplänter C., et al. IL-27 inhibits the development of regulatory T cells via STAT3. Int Immunol 2008, 20(2):223-234.
32. Batuman O., Go D., Clark L.T., Smith E.L., Clements P., Feit A., et al. Relationship between cytokine levels and coronary artery disease in women. Heart Dis 2001, 3(2):80-84.
33. Muhlestein J.B., Anderson J.L. Chronic infection and coronary artery disease. Cardiol Clin 2003, 21:333-362.
34. Jafarzadeh A., Esmaeel-Nadmi A., Shariat M. High Sensitivity C-Reactive Protein and Immunoglobulin G against Chlamydia Pneumoniae and Chlamydial Heat Shock Protein-60 in Ischemic Heart Disease. Iran J Immunol 2008, 5:51-56.